Physician

Aaron Brett Grotas, M.D.

According to 2025 Medicare claims, Aaron Grotas, M.D. (NPI: 1518092048) practices urology in the Nassau County-Suffolk County, NY market, with the plurality of this provider's patient population coming from Nassau, NY. This provider's primary affiliated billing organization is PRINE HEALTH MEDICAL GROUP, PLLC (NPI: 1144790163; TIN: 83-2668818) and primary practice location at 11557-9998. Grotas is affiliated with the Community Care of Brooklyn IPA, Inc. (ACO ID: A4723), Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171), and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under both the MSSP and REACH models.

Grotas' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 700 traditional Medicare patients, billed 8,303 HCPCS/CPT codes, and received $431,100 in Medicare payments. The top billing code was 93976 (Ultrasound of abdomen and pelvis artery and vein blood flow). Part D data shows 3,040 prescription claims across 630 beneficiaries totaling $584,735 in drug costs, led by Myrbetriq (Mirabegron). 2018 DME data shows 11 claims. Open Payments data shows 52 records totaling $1,333. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $218,139 to $584,735. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	659	4,062	$294,747
2016	689	4,146	$344,137
2017	693	3,878	$421,155
2018	674	3,623	$456,548
2019	636	3,647	$425,880
2020	641	4,275	$412,862
2021	713	4,344	$454,727
2022	663	4,715	$389,534
2023	699	7,438	$463,004
2024	700	8,303	$431,100

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	490	2,435	$218,139
2016	526	2,690	$220,750
2017	574	3,002	$237,342
2018	578	3,029	$300,005
2019	591	2,883	$231,711
2020	594	2,822	$267,115
2021	684	3,424	$391,539
2022	684	3,398	$519,529
2023	627	3,080	$568,820
2024	630	3,040	$584,735

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	73	$5,475
2016	N/R	26	$3,925
2017	N/R	N/R	N/R
2018	N/R	11	$62
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93976	Ultrasound of abdomen and pelvis artery and vein blood flow	365	431	$128
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	435	860	$99
84153	Psa (prostate specific antigen) measurement, total	218	304	$18
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	392	702	$14
81003	Automated urinalysis test	370	586	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Myrbetriq	Mirabegron	287	10,257	$158,229
Abiraterone Acetate	Abiraterone Acetate	20	840	$121,065
Erleada	Apalutamide	11	330	$81,564
Orgovyx	Relugolix	24	718	$63,794
Mirabegron Er	Mirabegron	31	1,410	$18,907

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	52	$1,333	Astellas Pharma US Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aaron Brett Grotas, M.D.?

Tedicare shows public-source Medicare data for Aaron Brett Grotas, M.D. (NPI 1518092048), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aaron Brett Grotas, M.D. have ACO affiliation data?

Aaron Brett Grotas, M.D. is shown with ACO affiliation data for Community Care of Brooklyn IPA, Inc. (MSSP, ACO ID A4723), Physician Leaders Direct Contracting Entity, LLC (REACH, ACO ID D0171), and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Aaron Brett Grotas, M.D.?

Aaron Brett Grotas, M.D. is linked to PRINE HEALTH MEDICAL GROUP, PLLC (billing NPI 1144790163) in the available physician profile data.

Does Aaron Brett Grotas, M.D. have Open Payments data?

Aaron Brett Grotas, M.D. has 52 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.